Local immunological factors associated with recurrence of mucosal leishmaniasis

Clinical Immunology

Volumn 128, Issue 3, 2008, Pages 442-446

  Tuon, Felipe Francisco ^a   Gomes Silva, Adriano ^b   Da Cruz, Alda Maria ^b   Duarte, Maria Irma Seixas ^a   Neto, Vicente Amato ^a   Amato, Valdir Sabbaga ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

American tegumentary leishmaniasis; Cytokines; Lesion inflammatory infiltrate; Mucosal leishmaniasis; Recurrence; T cell subsets

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; LEISHMANIASIS; MACROPHAGE; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS; RECURRENT INFECTION; RISK ASSESSMENT; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; KILLER CELLS, NATURAL; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, MUCOCUTANEOUS; LOGISTIC MODELS; MACROPHAGES; MALE; MIDDLE AGED; RECURRENCE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 49149106873     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.05.007     Document Type: Article

References (25)

1. Amato V.S., Tuon F.F., Bacha H.A., Neto V.A., and Nicodemo A.C. Mucosal leishmaniasis Current scenario and prospects for treatment. Acta Trop. 105 (2008) 1-9
2. Amato V.S., Boulos M.I., Amato, V N., and Filomeno L.T. The use of a silicone T tube for the treatment of a case of American mucocutaneous leishmaniasis with tracheomalacia. Rev. Soc. Bras. Med. Trop. 28 (1995) 129-130
3. Zajtchuk J.T., Casler J.D., Netto E.M., Grogl M., Neafie R.C., Hessel C.R., de Magalhaes A.V., and Marsden P.D. Mucosal leishmaniasis in Brazil. Laryngoscope 99 (1989) 925-939
4. Amato V.S., Duarte M.I., Nicodemo A.C., de Carvalho L.V., Pagliari C., da, V M., de Oliveira L.S., de Castro S.M., Uip D.E., Amato J.G., Amato, and V N. An evaluation of clinical, serologic, anatomopathologic and immunohistochemical findings for fifteen patients with mucosal leishmaniasis before and after treatment. Rev. Inst. Med. Trop. Sao Paulo 40 (1998) 23-30
5. Marsden P.D. Mucosal leishmaniasis ("espundia" Escomel, 1911). Trans. R. Soc. Trop. Med. Hyg. 80 (1986) 859-876
6. Brodskyn C.I., Barral A., Boaventura V., Carvalho E., and Barral-Netto M. Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis. J. Immunol. 159 (1997) 4467-4473
7. Bertholet S., Debrabant A., Caler E., Mendez S., Tabbara K.S., Belkaid Y., and Sacks D.L. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells. Infect. Immun. 73 (2005) 6620-6628
8. Amato V.S., Andrade H.F., Amato, V N., and Duarte M.I. Short report: persistence of tumor necrosis factor-alpha in situ after lesion healing in mucosal leishmaniasis. Am. J. Trop. Med. Hyg. 68 (2003) 527-528
9. Bacellar O., Lessa H., Schriefer A., Machado P., Ribeiro de J.A., Dutra W.O., Gollob K.J., and Carvalho E.M. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect. Immun. 70 (2002) 6734-6740
10. Da-Cruz A.M., Bittar R., Mattos M., Oliveira-Neto M.P., Nogueira R., Pinho-Ribeiro V., zeredo-Coutinho R.B., and Coutinho S.G. T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy. Clin. Diagn. Lab. Immunol. 9 (2002) 251-256
11. Pirmez C., Yamamura M., Uyemura K., Paes-Oliveira M., Conceicao-Silva F., and Modlin R.L. Cytokine patterns in the pathogenesis of human leishmaniasis. J. Clin. Invest. 91 (1993) 1390-1395
12. Faria D.R., Gollob K.J., Barbosa Jr. J., Schriefer A., Machado P.R., Lessa H., Carvalho L.P., Romano-Silva M.A., de Jesus A.R., Carvalho E.M., and Dutra W.O. Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect. Immun. 73 (2005) 7853-7859
13. Gomes-Silva A., de Cassia B.R., Dos Santos N.R., Amato V.S., da Silva M.M., Oliveira-Neto M.P., Coutinho S.G., and Da-Cruz A.M. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?. Clin. Exp. Immunol. 149 (2007) 440-444
14. Stenger S., Thuring H., Rollinghoff M., and Bogdan C. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180 (1994) 783-793
15. Stenger S., Donhauser N., Thuring H., Rollinghoff M., and Bogdan C. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J. Exp. Med. 183 (1996) 1501-1514
16. Tuon F.F., Amato V.S., Bacha H.A., Almusawi T., Duarte M.I., Amato, and V N. Toll-like receptors and leishmaniasis. Infect. Immun. 76 (2008) 866-872
17. Amato V.S., de Andrade H.F., and Duarte M.I. Mucosal leishmaniasis: in situ characterization of the host inflammatory response, before and after treatment. Acta Trop. 85 (2003) 39-49
18. Amato V., Amato J., Nicodemo A., Uip D., Amato Neto V., and Duarte M. Treatment of mucocutaneous leishmaniasis with pentamidine isothionate. Ann. Dermatol. Venereol. 125 (1998) 492-495
19. Franke E.D., Wignall F.S., Cruz M.E., Rosales E., Tovar A.A., Lucas C.M., Llanos-Cuentas A., and Berman J.D. Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis. Ann. Intern. Med. 113 (1990) 934-940
20. Tuon F.F., Amato V.S., Floeter-Winter L.M., Zampieri R.A., Amato, V N., Franca F.O., and Shikanai-Yasuda M.A. Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids - first report. Int. J. Dermatol. 46 (2007) 628-630
21. Hsu S.M., Raine L., and Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29 (1981) 577-580
22. Moussallem T.M., Guedes F., Fernandes E.R., Pagliari C., Andrade Jr. H.F., Duarte M.I., and Lancellotti C.L. Characterization of cellular phenotypes and cytokine expression in balt from children with congenital heart diseases. Pediatr. Pathol. Mol. Med. 22 (2003) 449-459
23. Brown D.R., Fowell D.J., Corry D.B., Wynn T.A., Moskowitz N.H., Cheever A.W., Locksley R.M., and Reiner S.L. Beta 2-microglobulin-dependent NK1.1+ T cells are not essential for T helper cell 2 immune responses. J. Exp. Med. 184 (1996) 1295-1304
24. Denkers E.Y., Gazzinelli R.T., Martin D., and Sher A. Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice. J. Exp. Med. 178 (1993) 1465-1472
25. Awasthi A., Mathur R.K., and Saha B. Immune response to Leishmania infection. Indian J. Med. Res. 119 (2004) 238-258